« Addressing Metabolic Dysfunction‑Associated Steatotic Liver Disease (MASLD) in Endocrinology Settings in Canada: From Prevalence to Patient-Centered Management ». Canadian Diabetes & Endocrinology Today, vol. 3, nᵒ s01, décembre 2025, p. 2–8, https://doi.org/10.58931/cdet.2025.3s0144.